To test the hypothesis that HB-EGF–EGFR signaling drives bone marrow angiogenesis and promotes MM progression, we studied the expression and activity of these proteins in bone marrow cells and tissues from MM and MGUS patients. The gene discussed is HBEGF; the disease is Miyoshi myopathy.